Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
2.8K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

5.4K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.4K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

2.8K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.8K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

681
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
681

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Temporal and Regional Circular RNA profiling in a Tauopathy Mouse Model: Implications for Tau Pathology and Neurodegeneration.

bioRxiv : the preprint server for biology·2026
Same author

Adherence to Mediterranean diet: a public health paradox.

International journal of food sciences and nutrition·2026
Same author

Necroptosis in Down Syndrome.

Cell death & disease·2026
Same author

TREM2 in neurodegeneration and diseases.

Molecular psychiatry·2026
Same author

Corrigendum to: Dual role of microglia in neuroinflammation and neurodegenerative diseases. [Neurobiology of Disease, Volume 216, November 2025, 107133].

Neurobiology of disease·2026
Same author

Amyloid-β and Tau in Alzheimer's disease: pathogenesis, mechanisms, and interplay.

Cell death & disease·2026

Related Experiment Video

Updated: Jun 25, 2025

Ultrasound Assessment of Endothelial Function: A Technical Guideline of the Flow-mediated Dilation Test
06:35

Ultrasound Assessment of Endothelial Function: A Technical Guideline of the Flow-mediated Dilation Test

Published on: April 27, 2016

17.5K

Endothelial dysfunction: mechanisms and contribution to diseases.

Amir Ajoolabady1, Domenico Pratico2, Jun Ren3

  • 1Department of Biomedical Engineering, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.

Acta Pharmacologica Sinica
|May 21, 2024
PubMed
Summary
This summary is machine-generated.

Endothelial dysfunction disrupts vascular homeostasis, impacting cardiovascular and metabolic diseases. This perspective explores new mechanisms and evaluates current preclinical therapeutic strategies for endothelial dysfunction.

Keywords:
endothelial dysfunctionextracellular matrix and cytoskeletonhyperglycemiainflammationmetabolic conditions

More Related Videos

Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research
08:42

Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research

Published on: October 22, 2014

27.3K
Assessing Endothelial Vasodilator Function with the Endo-PAT 2000
07:46

Assessing Endothelial Vasodilator Function with the Endo-PAT 2000

Published on: October 15, 2010

43.7K

Related Experiment Videos

Last Updated: Jun 25, 2025

Ultrasound Assessment of Endothelial Function: A Technical Guideline of the Flow-mediated Dilation Test
06:35

Ultrasound Assessment of Endothelial Function: A Technical Guideline of the Flow-mediated Dilation Test

Published on: April 27, 2016

17.5K
Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research
08:42

Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research

Published on: October 22, 2014

27.3K
Assessing Endothelial Vasodilator Function with the Endo-PAT 2000
07:46

Assessing Endothelial Vasodilator Function with the Endo-PAT 2000

Published on: October 15, 2010

43.7K

Area of Science:

  • Vascular Biology
  • Cell Biology
  • Pathophysiology

Background:

  • The endothelium, the inner lining of blood vessels, acts as the body's largest organ.
  • It regulates vascular tone, inflammation, and homeostasis, interacting with blood and lymphatic systems.
  • Endothelial dysfunction is a key factor in cardiovascular, cerebral, and metabolic diseases.

Purpose of the Study:

  • To explore recently identified mechanisms of endothelial dysfunction in various disease subsets.
  • To critically evaluate the strengths and limitations of current preclinical therapeutic interventions.

Main Methods:

  • This is an opinion/perspective piece.
  • It involves a review and critical evaluation of existing literature and preclinical data.

Main Results:

  • New mechanisms contributing to endothelial dysfunction across diverse diseases have been identified.
  • Current preclinical therapeutic interventions show variable strengths and limitations.

Conclusions:

  • Understanding novel mechanisms of endothelial dysfunction is crucial for developing effective treatments.
  • Further research and development are needed to overcome limitations in current preclinical therapies for endothelial dysfunction.